All official European Union website addresses are in the europa.eu domain.
See all EU institutions and bodiesAzoles are used as fungicides in pesticides, biocides and industry, as well as in medicines for people and animals. Resistance to azole medicines, where some people with Aspergillosis may not respond to the medicines available, is of increasing concern. EU agencies worked together, taking a One Health approach to assessing the risk posed by fungicides not used as human medicines.
Waterbase Water Quality data showed that there are places where concentrations of azoles in water exceeded safety thresholds.
Did you know?
Azoles can exceed thresholds considered to be safe in European water bodies, posing a risk to organisms in ecosystems
and have been widely used as pesticides in Europe, as well as biocides, in industry and as medicines
As medicines, azoles can be used to treat people with the lung disease Aspergillosis. Concern is increasing over the rise in resistance to the azole medicines used in Aspergillosis treatment.
9/20
countries with sites over quality threshold for tebuconazole
in surface waters
10
Countries monitored
for azoles
in groundwater
Exceedances of Azoles in European rivers, lakes and groundwater from 2020 to 2023
The map shows monitoring sites where countries have reported Azoles in rivers and lakes. As concentrations may be very low, these can be below reliable detection limits. Such points are below the Limit of Quantification (LOQ) (grey dots). Those above the LOQ are shown as blue (concentration below environmental safety threshold) or red, above that threshold.
Read more
Background information
Methodology
Related resources
EU agencies and One Health – useful links
Notes
- ↵Azoles are used to kill moulds. For some simple definitions read: https://www.efsa.europa.eu/en/plain-language-summary/azole-resistance-aspergillus-spp
- ↵Impact of the use of azole fungicides, other than as human medicines, on the development of azole-resistant Aspergillus spp. https://efsa.onlinelibrary.wiley.com/doi/full/10.2903/j.efsa.2025.9200